An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

Clinical trial NCT00818480 · COMPLETED

Trial details

NCT number: NCT00818480
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Melanoma Non-Hodgkin's Lymphoma

Start date: 2006-02-01
Primary completion: 2011-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.